ABIONYX Pharma: Monthly Statement of Total Voting Rights and Shares Forming the Company’s Share Capital
ABIONYX Pharma: Monthly Statement of Total Voting Rights and Shares Forming the Company’s Share Capital
Article L233-8-II of the French Commercial Code
Article 223-16 of the General Regulations of the AMF (French Financial Markets Authority)
Regulatory News:
ABIONYX Pharma (Paris:ABNX):
ABL Diagnostics: Information Relating to the Total Number of Voting Rights and the Total Number of Shares Composing the Share…
ABIONYX Pharma Announces the Success of its Financing for a Total Maximum Amount of EUR 33 M
ABIONYX Pharma Launches Fully Secured Capital Increase with Preferential Subscription Rights and Structured Debt Financing for an…
Theraclion: Monthly Information on the Total Number of Voting Rights and Shares Comprising the Share Capital
ABIONYX Pharma Provides an Update on Its Operations and Cash Position for the First Quarter of 2026
MaaT Pharma: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital
